Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.46 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL840920 | 0.92 | TYR (0.48) | TYRCYP3A4MAPTTP53ALOX5 | |
| SCHEMBL9027471 | 0.91 | TYR (0.43) | TYRCYP3A4MAPTTP53ALOX5 | |
| SCHEMBL28193225 | 0.89 | TYR (0.44) | TYRCYP3A4MAPTTP53ALOX5 | |
| SCHEMBL28306596 | 0.88 | TYR (0.47) | TYRCYP3A4MAPTTP53ALOX5 | |
| SCHEMBL11384230 | 0.86 | ALOX5 (0.40) | TYRCYP3A4MAPTTP53ALOX5 | |
| SCHEMBL728554 | 0.86 | LIPG (0.52) | MAPTALOX5ALOX15TLR8LIPG | |
| SCHEMBL3957214 | 0.84 | LIPG (0.55) | MAPTALOX5ALOX15TLR8LIPG | |
| SCHEMBL7933000 | 0.84 | LIPG (0.55) | MAPTALOX5ALOX15TLR8LIPG | |
| SCHEMBL27671384 | 0.83 | TYR (0.47) | TYRCYP3A4MAPTTP53ALOX5 | |
| SCHEMBL3664909 | 0.83 | TYR (0.43) | TYRCYP3A4MAPTTP53ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8187730-B2 | Acenaphthoquinoxaline derivative, light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-29 | — | — | US | disclosed |
| US-20090243476-A1 | Acenaphthoquinoxaline Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090243476-A1 | Acenaphthoquinoxaline Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device | ACE, ACE2, NQO1 | TYR 382/4885CYP3A4 131/4885MAPT 3114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.